top of page

Research Publications
Our Numbers
500+
Publications
49,600+
Total Times Cited
12,119
Most Times Cited
12+ Mil.
number of single cells analyzed
620 TB
of data generated
10.000+
Yearly Patient Screens
Publication List
Khodzhigorova A, Distler A, Dees C, Lang V, Sadowski A, Schneider H, Beyer C, Gelse K, Distler O, Schett G, Distler JH. Inhibition of sumoylation prevents experimental fibrosis. Ann Rheum Dis. Ann Rheum Dis. 2012 Aug 17. |
Weingärtner S, Zerr P, Tomcik M, Palumbo-Zerr K, Distler A, Dees C, Beyer C, Shankar SL, Cedzik D, Schafer PH, Distler O, Schett G, Distler JH. Pomalidomide is effective for prevention and treatment of experimental skin fibrosis. Ann Rheum Dis. Ann Rheum Dis. 2012 Aug 17. |
Teruel M, Simeon CP, Broen J, Vonk MC, Carreira P, Camps MT, Garcia-Portales R, Delgado-Frias E, Gallego M, Espinosa G, Ssg TS, Beretta L, Airo P, Lunardi C, Riemekasten G, Witte T, Krieg T, Kreuter A, Distler JH, Hunzelmann N, Koeleman BP, Voskuyl AE, Schuerwegh AJ, Gonzalez-Gay MA, Radstake TR, Martin J. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther. 2012 Jun 25;14(3):R154. |
Dees C, Tomcik M, Palumbo-Zerr K, Akhmetshina A, Beyer C, Lang V, Horn A, Zerr P, Zwerina J, Gelse K, Distler O, Schett G, Distler JH. JAK2 as a novel mediator of the pro-fibrotic effects of TGFβ in systemic sclerosis. Arthritis Rheum. 2012 May 1. |
Page 1 of 1
bottom of page
